agilon health, inc. Operating Cash Flow
agilon health, inc. (AGL) reported Operating Cash Flow of -$33.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- agilon health, inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$57.30M.
- agilon health, inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $23.73M.
- agilon health, inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$20.54M, a 225.08% decline year-over-year.
- agilon health, inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$18.15M.
- agilon health, inc. net cash provided by (used in) operating activities for fiscal 2025 was -$105.76M.
- agilon health, inc. net cash provided by (used in) operating activities for fiscal 2024 was -$57.78M.
- agilon health, inc. net cash provided by (used in) operating activities for fiscal 2023 was -$156.20M.
- agilon health, inc. net cash provided by (used in) operating activities for fiscal 2022 was -$130.81M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$57.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$33.57M 10-Q · filed 2026-08-05 | -$54.11M derived: sum of 3 quarters · filed 2026-08-05 | -$72.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $23.73M 10-Q · filed 2026-05-06 | $3.19M derived: sum of 2 quarters · filed 2026-05-06 | -$14.96M derived: sum of 3 quarters · filed 2026-05-06 | -$50.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$20.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$38.69M derived: sum of 2 quarters · filed 2026-02-25 | -$73.78M derived: sum of 3 quarters · filed 2026-08-05 | -$105.76M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$18.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$53.24M derived: sum of 2 quarters · filed 2026-08-05 | -$85.23M 10-Q · filed 2025-11-04 | -$68.81M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$35.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$67.07M 10-Q · filed 2026-08-05 | -$50.65M derived: sum of 3 quarters · filed 2026-08-05 | -$58.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$31.99M 10-Q · filed 2026-05-06 | -$15.57M derived: sum of 2 quarters · filed 2026-05-06 | -$23.27M derived: sum of 3 quarters · filed 2026-05-06 | -$41.99M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $16.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.72M derived: sum of 2 quarters · filed 2026-02-25 | -$10.00M derived: sum of 3 quarters · filed 2026-02-25 | -$57.78M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$26.42M derived: sum of 2 quarters · filed 2025-11-04 | -$74.20M 10-Q · filed 2025-11-04 | -$135.36M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$18.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$66.49M 10-Q · filed 2025-08-04 | -$127.66M derived: sum of 3 quarters · filed 2026-02-25 | -$140.68M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$47.78M 10-Q · filed 2025-05-06 | -$108.94M derived: sum of 2 quarters · filed 2026-02-25 | -$121.96M derived: sum of 3 quarters · filed 2026-02-25 | -$143.16M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$61.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$74.18M derived: sum of 2 quarters · filed 2026-02-25 | -$95.39M derived: sum of 3 quarters · filed 2026-02-25 | -$156.20M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$13.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$34.22M derived: sum of 2 quarters · filed 2024-11-07 | -$95.03M 10-Q · filed 2024-11-07 | -$144.99M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$21.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$82.02M 10-Q · filed 2024-08-06 | -$131.97M derived: sum of 3 quarters · filed 2025-02-25 | -$129.33M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$60.81M 10-Q · filed 2024-05-07 | -$110.77M derived: sum of 2 quarters · filed 2025-02-25 | -$108.12M derived: sum of 3 quarters · filed 2025-02-25 | -$168.39M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$49.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$47.31M derived: sum of 2 quarters · filed 2025-02-25 | -$107.58M derived: sum of 3 quarters · filed 2025-02-25 | -$130.81M 10-K · filed 2025-02-25 |
| 2022-09-30 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$57.62M derived: sum of 2 quarters · filed 2023-11-02 | -$80.85M 10-Q · filed 2023-11-02 | -$129.75M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$60.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$83.50M 10-Q · filed 2023-08-03 | -$132.39M derived: sum of 3 quarters · filed 2024-02-27 | -$151.54M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$23.23M 10-Q · filed 2023-05-09 | -$72.13M derived: sum of 2 quarters · filed 2024-02-27 | -$91.27M derived: sum of 3 quarters · filed 2024-02-27 | -$130.56M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$48.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$68.04M derived: sum of 2 quarters · filed 2024-02-27 | -$107.33M derived: sum of 3 quarters · filed 2024-02-27 | -$148.16M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$19.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$58.43M derived: sum of 2 quarters · filed 2022-11-03 | -$99.26M 10-Q · filed 2022-11-03 | -$112.60M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$39.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$80.12M 10-Q · filed 2022-08-04 | -$93.46M derived: sum of 3 quarters · filed 2023-03-01 | -$97.83M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$40.83M 10-Q · filed 2022-05-05 | -$54.17M derived: sum of 2 quarters · filed 2023-03-01 | -$58.53M derived: sum of 3 quarters · filed 2023-03-01 | -$67.91M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$13.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$17.71M derived: sum of 2 quarters · filed 2023-03-01 | -$27.08M derived: sum of 3 quarters · filed 2023-03-01 | -$53.20M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$4.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$13.74M derived: sum of 2 quarters · filed 2021-10-28 | -$39.87M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | -$9.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$35.50M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | -$26.13M 10-Q · filed 2021-05-26 | |||
| 2019-12-31 | -$103.86M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |